Readybio Pharmaceuticals Private Limited
Pharmaceutical company specializing in trading and wholesale of medicines.
2018 | Udaipur, Rajasthan (India) | Active
Readybio Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 9.97 M
- Revenue Growth 95.71%
- Profit Growth 61.54%
- Ebitda 142.10%
- Net Worth 81.81%
- Total Assets -1.21%
About Readybio Pharmaceuticals
Readybio Pharmaceuticals Private Limited (RPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 October 2018 (Six years and four months 29 days old ). Its registered office is in Udaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.97 M.
Sanjeev Kumar and Kanika Sharma serve as directors at the Company.
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909RJ2018PTC062550
- Company No.
062550
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Oct 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Pharma
What products or services does Readybio Pharmaceuticals Private Limited offer?
Readybio Pharmaceuticals Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Pharmaceutical Chemists.
Who are the key members and board of directors at Readybio Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjeev Kumar  | Director | 13-Dec-2018 | Current |
| Kanika Sharma | Director | 15-Apr-2022 | Current |
Financial Performance of Readybio Pharmaceuticals.
Readybio Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 95.71% increase. The company also saw a substantial improvement in profitability, with a 61.54% increase in profit. The company's net worth Soared by an impressive increase of 81.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Readybio Pharmaceuticals?
In 2021, Readybio Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹9.97 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Aug 2024 | Hdfc Bank Limited | ₹9.97 M | Open |
How Many Employees Work at Readybio Pharmaceuticals?
Unlock and access historical data on people associated with Readybio Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Readybio Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Readybio Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
